Inicio › Tumores cerebrales › Nueva York › New York City
Ensayos clínicos de Tumores cerebrales en New York City, NY
25 estudios para Tumores cerebrales buscan participantes en centros de New York City y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma
ReclutandoFase 2
- New York University Langone's Perlmutter Cancer Institute, New York
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
ReclutandoFase 2
- Columbia University Irving Medical Center, New York
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
ReclutandoFase 1/2
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
ReclutandoFase 2
- Local Institution - 0170, New York
- Memorial Sloan Kettering Cancer Center, New York
A Phase 1/1b Study of IAM1363 in HER2 Cancers
ReclutandoFase 1
- Icahn School of Medicine at Mount Sinai, New York
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
ReclutandoFase 2
- Memorial Sloan-Kettering Cancer Center, New York
Chronic CED of TPT for Recurrent Malignant Glioma
ReclutandoFase 1
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
ReclutandoFase 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
European Prospective Investigation Into Childhood Cancer
ReclutandoEstudio observacional
- Columbia University Irving Medical Center, New York
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
ReclutandoFase 1/2
- Lenox Hill Brain Tumor Center, New York
Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
ReclutandoFase 3
- Lenox Hill Brain Tumor Center, New York
Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma
Reclutando
- Lenox Hill Brain Tumor Center, New York
Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)
Reclutando
- Lenox Hill Brain Tumor Center, New York
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
ReclutandoFase 1/2
- Lenox Hill Brain Tumor Center, New York
A Study of Sotorasib in People With Brain Tumors
ReclutandoFase 1
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Brodalumab in the Treatment of Immune-Related Adverse Events
ReclutandoFase 1
- Columbia University Irving Medical Center, New York
rTMS for Postoperative Brain Tumor Patients
Reclutando
- Columbia University Irving Medical Center, New York
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
ReclutandoFase 1/2
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
ReclutandoFase 2
- Lenox Hill Brain Tumor Center, New York
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
ReclutandoFase 1/2
- Weill Cornell Medicine, New York
- Brooklyn Methodist Hospital - NewYork Presbyterian, New York
- New York Presbyterian Hospital - Queens, New York
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer
ReclutandoFase 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
FUS Etoposide for DMG
ReclutandoFase 1
- Columbia University Irving Medical Center, New York
Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer
ReclutandoFase 4
- New York-Presbyterian/Weill Cornell Medical Center, New York
Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
Reclutando
- Memorial Sloan Kettering Cancer Center, New York
Más información sobre Tumores cerebrales en MedlinePlus
Ensayos de Tumores cerebrales en otras ciudades
- Houston, TX35 estudios
- Boston, MA28 estudios
- Washington, DC20 estudios
- Los Angeles, CA16 estudios
- Miami, FL15 estudios
- Durham, NC14 estudios
- St. Louis, MO12 estudios
- Rochester, MN11 estudios
- Chicago, IL11 estudios
- Cleveland, OH11 estudios
- Baltimore, MD11 estudios
- Seattle, WA11 estudios
Otros estudios en New York City
- Cáncer de seno136 estudios
- Cáncer de pulmón de células no pequeñas121 estudios
- Cáncer (todos los tipos)109 estudios
- Cáncer de próstata103 estudios
- Cáncer metastásico93 estudios
- Cáncer del colon y del recto78 estudios
- Cáncer de ovario69 estudios
- Cáncer de pulmón60 estudios
- Mieloma múltiple60 estudios
- Cáncer de páncreas60 estudios
- Cáncer de endometrio52 estudios
- Leucemia mielógena aguda51 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.